StockWatch
·
PSP PROJECTS LTD · QQ1 FY-2027 · THE CALL

Strong revenue growth masks thin margins and execution risks

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsPSPPROJECTPSP Projects Ltd05 Aug 2026 · 6 min read
Verdict

Hold

confidence 5/10

Credibility

Grade B

Maintained FY27 revenue target (4,500 Cr) and margin guidance (7–8%); delivered numbers support execution, but thin margins and pending receivables reduce confidence.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Q1 delivered strong 65% revenue growth and expanded order book to ₹13,245 Cr with Adani backing, but NPM collapsed to 2.1% and EBITDA margin fell short of 7–8% guidance. Margin miss blamed on seasonal labor deficit and elevated employee costs; management expects recovery in H2. Key risk: past receivable collection issues (SDB ₹90 Cr, UP Medical ₹100 Cr) and order inflow guidance implicitly downgraded from ₹6,000–8,000 Cr to ₹4,000–5,000 Cr.

₹853.5 Cr

Revenue · +64.8% YoY

₹18.3 Cr

Reported PAT · +4232.2% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Strong 65% YoY revenue growth despite seasonal headwinds

MET

Delivered 853.5 Cr vs. 518 Cr YoY, confirmed 65% growth. Q1 is seasonally weak.

EBITDA margin 6.4% reflects Q1 labor deficit, expect 7–8% in H2

Partial

Actual 6.4% EBITDA margin. Employees 5.39% of sales (vs. normal 4–4.5%). Explanation: Apr–May labor shortage, June revenue 319 Cr (higher). Credible but execution risk remains.

NPM improvement from 0.07% to 2.12% is substantial

MET

Verified: 37 lakh to 18.3 Cr YoY. But 2.12% NPM is VERY thin; breaks down to ₹55 Cr EBITDA on ₹853 Cr revenue.

Order book 13,245 Cr provides multi-year visibility; 70% from Adani

MET

Order book confirmed; 70% within-group (Adani), 30% external. Concentration risk high if Adani orders slow.

Order inflows ₹4,000–5,000 Cr FY27 remain in prior range

OVERSTATED

Prior guidance ₹6,000–8,000 Cr. MD now says ₹4,000–5,000 Cr. Implicit downgrade from 6,000–8,000 to 4,000–5,000.

Debt-free within a year (prior FY26 call guidance)

MISS

Now guided as 2–3 quarters (by early 2027). Long-term debt ₹38 Cr, short-term ₹217 Cr; working capital facilities still utilized ₹844 Cr. Slipping timeline.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Order inflow guidance downgraded

Downgrade

Prior FY26 calls: ₹6,000–8,000 Cr expected. MD now implies ₹4,000–5,000 Cr FY27. Soft language ('will be in same range') masks a 25% reduction.

Debt-free timeline slipped

Downgrade

FY26 guidance: 'within one year' (by June 2027). Now: 'within 2–3 quarters' (Oct–Dec 2026). Still on track but not ahead of plan.

Margin recovery pushed to H2

Neutral

EBITDA margin 6.4% (vs. 7–8% guidance). Management attributes to seasonal labor deficit; expects recovery as June performance (₹319 Cr revenue) validates acceleration into core construction phase.

Employee team scaled 1.5–2x from prior year

Upgrade

Headcount 2,400 → 2,600. Employee cost 5.39% of sales (temporary excess to execute scaled order book). Management targets return to 4–4.5% as utilization improves.

The Q&A

Analysts pressed hard on margin credibility (3 questions). MD defended with detailed labor-cost breakdown but offered no guardrails. Receivables (SDB, UP Medical) mentioned without follow-up. One analyst accepted soft order inflow guidance without pushing for explicit prior-guidance retraction.

The exchanges that mattered

Revenue guidance reaffirmation — Shravan Shah, Dolat Capital

Answered

Yes, will be more than 25% on average, between ₹4,400–4,500 Cr. Remain in same line.

EBITDA margin timing — Shravan Shah, Dolat Capital

Answered

H2 only due to seasonal labor deficit. April–May sales weak, June ₹319 Cr shows acceleration. If loss due to labor deficit factored in, EBITDA above 7%. Better in Q3–Q4.

Order inflow run-rate — Shravan Shah, Dolat Capital

Partial

Probably same range, ±₹400–500 Cr, remains ₹4,000–5,000 range. Projects under discussion for Q2–Q3.

Working capital trajectory — Shravan Shah, Dolat Capital

Answered

Yes, we can expect so.

Mumbai project execution status — Balasubramanian, Arihant Capital

Answered

Mahim: raft foundation done, first basement floor underway. Matunga: sheet piling ongoing before excavation.

Mobilization advance terms — Balasubramanian, Arihant Capital

Answered

The whole amount is interest-free.

Commonwealth project timeline — Dhananjay Mishra, Centrum Broking

Answered

No clear timeline yet; control room just started. Probably next quarter heard. Not in FY27 order inflow guidance (government projects counted in bid pipeline only).

UP Medical receivable resolution — Dhananjay Mishra, Centrum Broking

Answered

Three projects near EOT signing. Discussion in Lucknow last Monday. Expect EOTs by weekend/first week Aug. Money due. Account close end-Aug/mid-Sep. Unbilled ₹60 Cr + receivable ₹40 Cr will materialize.

EBITDA margin guidance upside — Ayush Saboo, Choice Institutional Equities

Answered

H2 only. As execution speeds up in next few quarters, should be in better position to go beyond 7–8%.

SDB receivable update — Vaibhav Shah, JM Financial

Dodged

No clarity. Called for discussion with top management/board. Visiting next week. They reached out to meet but unknown positive direction. Outstanding ₹90 Cr.

Margin guidance scope (full-year vs. H2) — Vaibhav Shah, JM Financial

Partial

Should be for full year. Once execution speed picks up in next quarters, should be in better position to go beyond 7–8%.

Consolidated vs. standalone revenue — Vaibhav Shah, JM Financial

Answered

Subsidiary company executes ₹80 Cr miscellaneous Adani projects. All future guidance will be on console basis only.

Dharavi order book composition — Vishal Periwal, PL Capital

Answered

Two projects, ₹3,000 Cr. At ₹10–12 lakh/house (₹3,000–3,500 per sq ft), equals 30,000–32,000 houses out of total 2 lakh houses.

Dharavi follow-on opportunities — Vishal Periwal, PL Capital

Answered

Depends on performance on current two. Foundation complexity high. Once stable on these, can always start new site. Right of first refusal if perform well.

Labor deployment scale — Vishal Periwal, PL Capital

Answered

Difficult to compare (project-specific). Currently 16,000–17,000 needed, almost full. Peak could add 3,000–4,000 more in next 1–2 quarters as activities diversify.

Inflation impact on cost-plus contracts — Jainam Jain, Dam Capital

Answered

Most Adani projects are pass-through cost (no impact). 30% external book (INR 5,500–6,000 Cr older projects) mostly complete. Few activities at SMC & RVNL impacted by aluminum/copper inflation; minor.

Segment diversification (new verticals post-Adani) — Jainam Jain, Dam Capital

Answered

No. Focus on buildings only (industry, data center, commercial, hotel, hospital). Not infrastructure or non-building work.

Geographic expansion plans — Rushabh, RBSA Investment

Answered

No. Focusing on Gujarat & Mumbai only. 25% non-Adani, 70–75% Adani target. Sufficient visibility for 2 years, not entering new regions yet.

Team capability scaling — Rushabh, RBSA Investment

Answered

Employee expense up (building team to 1.5–2x from last year). Strengthening to get more Adani orders and deliver on time.

Data center segment opportunity — Jainam Shah, Equirus Securities

Partial

Not focused on Mumbai/Visakhapatnam data centers yet. Dholera (Gujarat) has two lands (data center + defense). Could come later. MediCity & housing projects (Mundra, Ahmedabad) starting soon.

Precast segment contribution — Urviben Patel, Infinite Wealth Advisors

Partial

No separate revenue tracking; embedded in project revenue. Plant capacity ₹200 Cr/year, executing ₹150–200 Cr. Margin same as overall business (Adani projects only, no other customers).

Dharavi house-count and project sizing — Shravan Shah, Dolat Capital (repeat)

Answered

Lesser number. ₹3,000 Cr, ₹10–12 lakh per house = 30,000 houses (out of 2 lakh total). Two projects building 30,000–32,000 houses now.

Tax rate normalization — Shravan Shah, Dolat Capital (repeat)

Answered

Slightly higher due to non-deductible expenses (permanent difference). Will remain elevated vs. 25%.

Cash balance trajectory — Shravan Shah, Dolat Capital (repeat)

Answered

Yes, same level, slightly higher.

Cost-plus formula on Adani projects — Sanjay Kohli, Goldstone Capital

Answered

Cost-plus percentage on overall project cost (materials, labor, overhead). Not separate per-material margin. Total EBITDA level: Adani projects 6–7%, PSP projects 8–9%. Cost-plus effectively 7% EBITDA. Item-rate contract; material base rate quoted, actual difference paid in bill.

Cost-plus range variability — Sanjay Kohli, Goldstone Capital

Answered

Always 1–2% gap in execution. Standardized by project type. Mumbai +3%, Mundra +1.5%. Overhead varies by project performance (can save 1–1.5% if project runs fast).

Guidance

Forward guidance and management's confidence

FY27 ₹4,400–4,500 Cr (20%+ growth)

High

On track. Q1 seasonally weak; accelerating from June baseline. Order book ₹13,245 Cr supports full-year execution >₹4,000 Cr.

EBITDA margin 7–8% (H2 focus, full year aspiration)

Medium

Q1 at 6.4% due to seasonal labor deficit & elevated employee costs. Management claims 1% margin leakage from April–May underperformance. Credible recovery if June acceleration sustains.

Employee costs normalize to 4–4.5% of revenue from current 5.39%

Medium

Team expansion (2,400 → 2,600) and April increments temporary. Normalization depends on higher absolute revenue.

Capex 3–4% of revenue

High

Q1 delivered ₹28 Cr (3.3%). MD confirms 3–4% range on average; specific large projects may spike slightly.

Risks the call surfaced

Ranked by how much they should concern a holder

Customer concentration

High

70% of order book from Adani Group. ~45% of Q1 revenue from Adani. If Adani Group orders slow or investment cycle contracts, PSP exposed to ~40% revenue drop.

Margin credibility

High

NPM at 2.1% (₹18.3 Cr on ₹853.5 Cr). EBITDA 6.4% below 7–8% guidance. Employee costs still 5.39% (vs. 4–4.5% normal). If labor inflation persists or execution slows, margins compress further.

Receivable collection

Medium

SDB receivable ₹90 Cr (stuck; MD visiting next week, no timeline). UP Medical ₹100 Cr (₹60 Cr unbilled, ₹40 Cr receivable) expected to close by mid-Sep 2026. Combined ₹190 Cr at risk if customers delay further.

Execution capability

Medium

Q1 saw labor deficit in Apr–May; June recovered but dependent on sustained availability. Dharavi project (30,000+ houses) is largest yet; any execution slip could damage 'right of first refusal' for phase 2. SMC & RVNL impacted by aluminum/copper inflation.

Guidance credibility

Medium

Prior FY26 guidance: ₹6,000–8,000 Cr order inflows. Current call implies ₹4,000–5,000 Cr. MD used soft language ('same range') but new numbers are lower. If H2 misses even ₹4,000–5,000 Cr target, credibility dents further.

Management

Score 6/10. Clear on execution updates & project-level details. Defensive on margin misses; used technical explanations (seasonal labor deficit, employee scaling) to justify shortfalls. Evasive on SDB receivable (no timeline). Met revenue growth target (65% YoY). Missed EBITDA margin guidance (6.4% vs. 7–8%). Implicit downgrade on order inflows (₹6,000–8,000 → ₹4,000–5,000). Past receivable collection issues (SDB, UP Medical) not fully resolved.

What to watch next
  • 1 · Q2–Q3 FY27

    Labor normalization & H2 margin recovery to 7–8% EBITDA target

  • 2 · Aug–Sep 2026

    UP Medical ₹100 Cr receivable materialization; SDB ₹90 Cr resolution

  • 3 · H2 FY27

    Commonwealth Games Ahmedabad tender (uncertain timing, not in FY27 order inflow guidance)

Key risk: past receivable collection issues (SDB ₹90 Cr, UP Medical ₹100 Cr) and order inflow guidance implicitly downgraded from ₹6,000–8,000 Cr to ₹4,000–5,000 Cr.

Informational and educational content only. Not investment advice.